$OPXA Headlines Opexa, BreitBurn, Hudson Pacific price

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$OPXA Headlines

Opexa, BreitBurn, Hudson Pacific price offerings 12:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 9:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 4:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 12:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 10:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy

US Stock Futures Up; Fed Decision In Focus 5:49 a.m. Dec. 18, 2013 - benzinga.com
Opexa Therapeutics Prices 4.12M Share Offering at/$1.70/Share 4:58 a.m. Dec. 18, 2013 - benzinga.com
Opexa Converts all Convertible Secured Promissory Notes into Common Stock 4:32 a.m. Sept. 25, 2013 - benzinga.com
Weekly CFO Buys Highlight 11:32 a.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 1:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 2:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 8:56 a.m. Aug. 8, 2013 - 247WallSt.com
Opexa Therapeutics Prices 12M Share Offering at $1.50/Share 8:06 p.m. Aug. 7, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 2:36 p.m. Aug. 7, 2013 - 247WallSt.com
Morning Market Losers 8:09 a.m. May 14, 2013 - benzinga.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 2:25 a.m. April 8, 2013 - InvestorPlace.com
10-K: OPEXA THERAPEUTICS, INC. 8:16 a.m. March 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 8:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 2:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 8:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 9:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 3:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 2:22 p.m. Feb. 14, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com


Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 10:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 9:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 4:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 8:00 a.m. Dec. 16, 2013 - BusinessWire
New Supply Agreements and Analytical Tools, Expansions, Conference Presentations and Financial Results - Research Report on WuXi PharmaTech, Sirona, ICON, Opexa Therapeutic and Karyopharm Therapeutics 9:04 a.m. Nov. 20, 2013 - PR Newswire
Opexa Therapeutics Selected as a "Top 10 Advanced Therapy Projects to Watch" 9:00 a.m. Nov. 12, 2013 - BusinessWire
Opexa CEO Invited to Join Personalized Medicine Panel at New York CEO Conference 9:00 a.m. Nov. 8, 2013 - BusinessWire
Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update 4:05 p.m. Nov. 7, 2013 - BusinessWire
CORRECTING and REPLACING Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:51 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:00 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS 8:00 a.m. Oct. 23, 2013 - BusinessWire
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews 8:00 a.m. Oct. 21, 2013 - BusinessWire
Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24 12:01 p.m. Oct. 18, 2013 - GlobeNewswire
The RedChip Money Report TV Show Now Airing Weekly on Bloomberg Europe: 139 Million Homes 10:30 a.m. Oct. 17, 2013 - GlobeNewswire
Opexa Therapeutics CEO to Appear on The RedChip Money Report on Fox Business News 8:00 a.m. Oct. 17, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 4:15 p.m. Oct. 8, 2013 - BusinessWire
Opexa Therapeutics' CEO Featured in Leading Life Science Publication 8:00 a.m. Oct. 7, 2013 - BusinessWire
Opexa Therapeutics' Therapy for Multiple Sclerosis Featured in FOX Television News Story 8:00 a.m. Oct. 2, 2013 - BusinessWire
Opexa CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting 8:00 a.m. Sept. 30, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tripadvisor Faces Investigation Over Securities Violations

Updated Category News Views 58

Tripadvisor's Stock Dive: Investor Panic or Opportunity? Woah, if you had a stake in Tripadvisor (NASDAQ: TRIP) recently, you know it hasn't been a walk in the park. Shares took a nosedive of over 20% on November 5, 2026, after they unveiled a frightening $313.1 million net loss for the third quarter. What stirred the pot, you ask? Well, toss in a goodwill impairment...

Continue Reading
D-Wave Faces Lawsuit: Investors Eye Legal Action

Updated Category News Views 102

Securities Lawsuit Shakes D-Wave Quantum Inc. New York's legal corridors are buzzing with news that D-Wave Quantum Inc. (NASDAQ: QBTS) is getting hauled into court over alleged securities law violations. Shareholders who bought into QBTS stock between late February and late August of 2026 now find themselves caught in a lawsuit that's raising eyebrows all around Wall...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 126

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Greenberg Traurig Impresses with High Honors in Florida

Updated Category News Views 113

Legal Powerhouse Garners Accolades You know it's a big deal when a law firm like Greenberg Traurig gets the spotlight at the Florida Legal Luminaries Gala. Held on October 29 in the scenic Key Biscayne, this event was all about recognizing who’s who in the high-stakes world of law. Greenberg Traurig walked away with the 'Best Large Law Firm' award, cementing its stature...

Continue Reading
Netcapital Faces Fraud Lawsuit: Investor Impacts Unravel

Updated Category News Views 42

Investors Caught in Netcapital's Storm Well, here we are, back on the wild roller coaster that is the stock market, and boy, has Netcapital Inc. landed itself in a mess. The company's been hit with a securities fraud class action lawsuit thanks to allegedly cooking up fake consulting agreements that padded their revenues by a cool $14 million. That’s not just pocket...

Continue Reading
Soligenix Holds Steady Amidst Shifting Financial Landscape

Updated Category News Views 7

Stepping into Soligenix's News Every time Soligenix pops up on the radar, it feels like we're watching a biopharma soap opera. This time, they're juggling updates and quarterly numbers that scream both promise and peril. The New Jersey-based company, known for its focus on niche markets with unmet medical needs, tossed out some shiny clinical developments alongside a...

Continue Reading
WebAI Debuts Mac App for On-Device AI Prowess

Updated Category News Views 93

WebAI Breaks the Cloud AI Mold Listen, the tech landscape just got a little more interesting. With webAI's latest move, the game has shifted for those who live and breathe AI but aren't keen on their files dancing across the internet. Their new Mac app lets you run AI models without the cloud's watchful eye—or its per-token charges. Finally, some privacy in this digital...

Continue Reading
Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 6

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
ACT Expands with Broker-Dealer Arm for New Horizons

Updated Category News Views 120

Kicking Open New Doors: ACT's Bold Move Fancy a move with bigger stakes? ACT Capital Advisors just shook the tree, launching a broker-dealer affiliate, ACT Capital Markets. This outfit’s strutting with a brand-new set of services beyond the regular M&A dance, offering capital-raising and financing solutions. It’s not just expanding a portfolio—it’s widening the...

Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict

Updated Category News Views 44

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Continue Reading

Top 5 Most Recently Viewed Articles

Apollo Global Management's Options Trends and Insights Revealed

Updated Category News Views 230

Understanding Options Trading for Apollo Global Management In the world of finance, significant investors known as "whales" are displaying a notably bearish attitude towards Apollo Global Management. This behavior can be prominent in the options marketplace, where traders are actively expressing their expectations for the stock's future movement. An analysis of the...

Continue Reading
HTX Climbs the Ranks: Establishing Trust in the Web3 Space

Updated Category News Views 208

HTX's Remarkable Ascent in Global Crypto Rankings HTX, a prominent player in the cryptocurrency exchange arena, has recently announced a significant leap in its global standings on major cryptocurrency tracking platforms. This impressive improvement illustrates HTX's growing appeal and solidifies its position as a trusted authority in the international crypto community....

Continue Reading
Rush Enterprises, Inc. Sees Strong Q3 Results and Dividend Declaration

Updated Category News Views 155

Strong Financial Performance by Rush Enterprises, Inc. Rush Enterprises, Inc. (NASDAQ: RUSHA, RUSHB) has released its financial results for the third quarter, highlighting robust revenue streams despite facing some challenges in the commercial vehicle market. The company reported total revenues of approximately $1.9 billion, alongside a net income of $79.1 million. This...

Continue Reading
Avenue Living Secures Major Growth Milestone with Unencumbered Assets

Updated Category News Views 254

Avenue Living Achieves Significant Milestone in Unencumbered Assets Calgary-based Avenue Living has hit a remarkable benchmark in its capital management strategy by amassing nearly $800 million in unencumbered assets. As one of North America's rapidly growing private real estate investment firms, this significant achievement positions Avenue Living at the forefront of the...

Continue Reading
In-Depth Analysis of Options Trading for Walt Disney Stock

Updated Category News Views 139

Strong Activity in Options Trading for Disney Recent movements in the options market highlight a strong bullish sentiment surrounding Walt Disney (NYSE: DIS). A thorough examination of options history reveals that institutional investors, often referred to as 'smart money,' are actively placing significant bets that point to an optimistic outlook for the company. Notably,...

Continue Reading